Discovery and Optimization of a Series of 2-Aryl-4-Amino-5-(3′,4′,5′-trimethoxybenzoyl)Thiazoles as Novel Anticancer Agents
作者:Romeo Romagnoli、Pier Giovanni Baraldi、Maria Kimatrai Salvador、Delia Preti、Mojgan Aghazadeh Tabrizi、Andrea Brancale、Xian-Hua Fu、Jun Li、Su-Zhan Zhang、Ernest Hamel、Roberta Bortolozzi、Elena Porcù、Giuseppe Basso、Giampietro Viola
DOI:10.1021/jm300388h
日期:2012.6.14
inhibitors based on the 2-aryl/heteroaryl-4-amino-5-(3′,4′,5′-trimethoxybenzoyl)thiazole scaffold was synthesized and evaluated for growth inhibition activity on a panel of cancer cell lines, cell cycle effects, and in vivo potency. Structure–activity relationships were elucidated with various substitutions at the 2-position of the thiazole skeleton. Hydrophobic moieties, such as phenyl and 3-thienyl
合成了一系列基于 2-aryl/heteroaryl-4-amino-5-(3',4',5'-trimethoxybenzoyl)thiazol 支架的微管蛋白聚合抑制剂,并评估了对一组癌细胞的生长抑制活性系、细胞周期效应和体内效力。通过噻唑骨架 2 位的各种取代阐明了构效关系。疏水部分,如苯基和 3-噻吩基,在该位置具有良好的耐受性,苯基取代基的变化对效力有显着影响。活性最强的化合物 ( 3b ) 通过线粒体途径诱导细胞凋亡,同时激活 caspase-3。我们还表明它具有潜在的抗血管活性,因为它在体外减少了在非细胞毒性浓度下内皮细胞迁移和毛细管样管形成中断。此外,化合物3b显着降低了裸鼠模型中 HT-29 异种移植物的生长,表明3b是一种有前途的新型抗有丝分裂剂,具有临床潜力。